Immune Status of Cervical Lymph Nodes in Head and Neck Cancer-A Surgical Oncology Perspective

Neck dissection for cervical lymph node metastasis is an established procedure for head and neck cancer (HNC). However, with the advent of immunotherapy, head and neck surgical oncologists need to rethink removing all lymph nodes, including those with immune function. We investigated the anti-cancer immune response of the cervical lymph nodes in four patients with human papillomavirus type 16 (HPV16)-positive head and neck squamous cell carcinoma. Using lymphocytes extracted from local, metastatic, and non-metastatic lymph nodes and peripheral blood from these patients, we performed an intracellular flow cytometric cytokine assay using anti-IFN & gamma; and anti-TNF-& alpha; monoclonal antibodies to detect HPV16 E6- and E7-specific T cells. HPV status and p16 immunostaining were determined by in situ detection using the HPV RNAscope method and immunohistochemistry. In one case, E6-specific and E7-specific CD8+ T cells were detected in proximal metastatic nodes and distal non-metastatic nodes. This finding suggests that non-metastatic nodes should be preserved for their immune function during neck dissection and that the immune function of non-metastatic lymph nodes is important when administering immunotherapy. In this context, head and neck surgical oncologists treating HNC should consider the place of immunotherapy and neck dissection in the treatment of HNC.

Automated summary

Neck dissection is a commonly used procedure for treating cervical lymph node metastasis in head and neck cancer patients. However, with the emergence of immunotherapy, the removal of lymph nodes with immune function needs to be reconsidered. A study on HPV16-positive head and neck squamous cell carcinoma patients found that preserving non-metastatic lymph nodes is important for their immune function during neck dissection and when administering immunotherapy. Head and neck surgical oncologists should consider the role of immunotherapy and neck dissection in the treatment of head and neck cancer.